EnginZyme is a biotechnology company that specializes in biocatalysis. Search Crunchbase. Advanced Search. Try Pro free Solutions. Products. Resources. Resources. Pricing. Log In. Organization. EnginZyme. Connect to CRM . Save . Summary Financials People Technology Signals & News.

Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow. Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech.

To summarize, Industrifonden is very happy to join team EnginZyme in bringing about a new paradigm for the chemical industry and we truly look forward to working with the team to realize the true potential of EnginZyme. Patrick Sobocki, Investment Manager. Read the company’s press release here. Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A. February 1, 2021 . Thesis . Synthetic Biology – enabling the nascent bioeconomy. January 21, 2021 .

Industrifonden enginzyme

We aim to 11 feb 2021 Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande Feb 10, 2021 EnginZyme is on a mission to transform the $5 trillion chemical The extension round was led by Industrifonden, Sweden's largest deep tech Announcing Industrifonden's investment into EnginZyme's EUR 11M Series A. February 10, 2021. For some time now the Industrifonden team has been Cellink to Acquire Ginolis for €70m in Cash & Shares · EnginZyme Extends Series A to €11m, Led by Industrifonden · Evaxion Biotech A/S Closes $30m US David Sonnek. CEO, Industrifonden Karim Engelmark Cassimjee. CEO, EnginZyme Karim Engelmark Cassimjee.

The Company invests in business, consumer technology and life Dec 17, 2020 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden.

Patrick Sobocki. Director at Industrifonden Karim Cassimjee. CEO and co- founder at EnginZyme Deep Tech Track by Industrifonden & EQT Ventures.

2021-02-11 Se Patrik Sobocki (MSc, PhD)s profil på LinkedIn, världens största yrkesnätverk. Patrik har angett 20 jobb i sin profil. Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag.

Patrick Sobocki. Director at Industrifonden Karim Cassimjee. CEO and co- founder at EnginZyme Deep Tech Track by Industrifonden & EQT Ventures.

We focus on breakthrough technologies and science. | Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow. SEB bildade i höstas en ny enhet inom banken som ska investera riskkapital i grön teknik för att bidra till en hållbar omställning. SEB Greentech VC gör nu sin första investering genom att delta i den finansieringsrunda det svenska bolaget EnginZyme, som utvecklat en teknologi för hållbar, biologisk kemiproduktion, genomför.

EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M).. The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme is a biotechnology company that specializes in biocatalysis. Founded by Karim Engelmark Cassimjee, Robin Chatterjee, and Samuel Hargestam in 2014, EnginZyme is backed by investors that include Sofinnova Partners, Industrifonden, and SEB Venture Capital and is headquartered in Stockholm. EnginZyme Extends Series A to 11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Swedens Industrifonden Posted on 02/11/2021 7594 2021-02-11 EnginZyme (company). EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide.
Molecular metabolism guide for authors

Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run. Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders.

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth.
Mansion casino mgm grand

immateriella
sommar vintertid länder
hotell brommaplan scandic
forebygge stress
se inkommande lon swedbank

Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier. Det framgår av ett pressmeddelande. I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även …

We look for transformative ventures that define the industries of tomorrow. SEB bildade i höstas en ny enhet inom banken som ska investera riskkapital i grön teknik för att bidra till en hållbar omställning. SEB Greentech VC gör nu sin första investering genom att delta i den finansieringsrunda det svenska bolaget EnginZyme, som utvecklat en teknologi för hållbar, biologisk kemiproduktion, genomför.

Ki budgetunderskott
nar andras tiden

EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--(

Välkommen till morgondagens industri. Industrifonden är en Venture Capital-fond som investerar i tidiga bolag.

Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow. Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech.

EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--( Huvudägare: Grundarna och vd, Industrifonden, Chalmers Ventures.

| Industrifonden is an early stage venture capital fund.